HomeFATE • NASDAQ
add
Fate Therapeutics Inc
Previous close
$3.22
Day range
$2.91 - $3.27
Year range
$1.63 - $8.83
Market cap
347.33M USD
Avg Volume
1.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 6.77M | 625.83% |
Operating expense | 17.25M | -23.74% |
Net income | -38.43M | 27.16% |
Net profit margin | -567.44 | 89.96% |
Earnings per share | -0.33 | 38.89% |
EBITDA | -40.36M | 30.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 304.88M | -19.33% |
Total assets | 528.82M | -9.57% |
Total liabilities | 131.84M | -10.32% |
Total equity | 396.98M | — |
Shares outstanding | 113.88M | — |
Price to book | 0.92 | — |
Return on assets | -20.52% | — |
Return on capital | -21.98% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -38.43M | 27.16% |
Cash from operations | -32.31M | -13.38% |
Cash from investing | -53.37M | -260.92% |
Cash from financing | 1.27M | 2,096.55% |
Net change in cash | -84.40M | -1,883.71% |
Free cash flow | -28.37M | -111.77% |
About
Founded
2007
Website
Employees
181